Gennadiy Koev

1.9k total citations
25 papers, 1.3k citations indexed

About

Gennadiy Koev is a scholar working on Hepatology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Gennadiy Koev has authored 25 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hepatology, 15 papers in Infectious Diseases and 9 papers in Epidemiology. Recurrent topics in Gennadiy Koev's work include Hepatitis C virus research (17 papers), HIV/AIDS drug development and treatment (12 papers) and Hepatitis B Virus Studies (9 papers). Gennadiy Koev is often cited by papers focused on Hepatitis C virus research (17 papers), HIV/AIDS drug development and treatment (12 papers) and Hepatitis B Virus Studies (9 papers). Gennadiy Koev collaborates with scholars based in United States, United Kingdom and Ireland. Gennadiy Koev's co-authors include Woutrina A. Miller, W. Allen Miller, Edward Tam, Warren M. Kati, Akhteruzzaman Molla, Rubina Mondal, Preethi Krishnan, Barry Bernstein, Rakesh Tripathi and Hongmei Mo and has published in prestigious journals such as New England Journal of Medicine, Hepatology and Analytical Biochemistry.

In The Last Decade

Gennadiy Koev

25 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gennadiy Koev United States 19 703 564 429 304 237 25 1.3k
Eric Ferrari United States 13 864 1.2× 581 1.0× 492 1.1× 84 0.3× 470 2.0× 17 1.4k
Shihyun You United States 14 485 0.7× 466 0.8× 434 1.0× 108 0.4× 414 1.7× 21 1.4k
Lucyna Cova France 26 718 1.0× 1.1k 2.0× 511 1.2× 140 0.5× 333 1.4× 71 1.7k
B. Wolanski United States 15 304 0.4× 399 0.7× 402 0.9× 123 0.4× 478 2.0× 25 1.1k
Kenneth A. Stapleford United States 22 119 0.2× 207 0.4× 621 1.4× 215 0.7× 478 2.0× 40 1.5k
Takashi Shimoike Japan 17 449 0.6× 362 0.6× 237 0.6× 30 0.1× 391 1.6× 24 1.1k
Burton Beames United States 16 468 0.7× 515 0.9× 285 0.7× 141 0.5× 431 1.8× 17 1.1k
Katherine J. Denniston United States 10 562 0.8× 668 1.2× 204 0.5× 38 0.1× 202 0.9× 15 893
Kevin Whitby United Kingdom 14 423 0.6× 529 0.9× 775 1.8× 55 0.2× 348 1.5× 20 1.7k
Jacquelyn Wright-Minogue United States 13 549 0.8× 435 0.8× 294 0.7× 34 0.1× 178 0.8× 17 840

Countries citing papers authored by Gennadiy Koev

Since Specialization
Citations

This map shows the geographic impact of Gennadiy Koev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gennadiy Koev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gennadiy Koev more than expected).

Fields of papers citing papers by Gennadiy Koev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gennadiy Koev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gennadiy Koev. The network helps show where Gennadiy Koev may publish in the future.

Co-authorship network of co-authors of Gennadiy Koev

This figure shows the co-authorship network connecting the top 25 collaborators of Gennadiy Koev. A scholar is included among the top collaborators of Gennadiy Koev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gennadiy Koev. Gennadiy Koev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kati, Warren M., Gennadiy Koev, Michelle Irvin, et al.. (2014). In Vitro Activity and Resistance Profile of Dasabuvir, a Nonnucleoside Hepatitis C Virus Polymerase Inhibitor. Antimicrobial Agents and Chemotherapy. 59(3). 1505–1511. 88 indexed citations
2.
Lawitz, Eric, Fred Poordad, Kris V. Kowdley, et al.. (2013). A phase 2a trial of 12-week interferon-free therapy with two direct-acting antivirals (ABT-450/r, ABT-072) and ribavirin in IL28B C/C patients with chronic hepatitis C genotype 1. Journal of Hepatology. 59(1). 18–23. 55 indexed citations
3.
Randolph, John T., Peggy Huang, Rolf Wagner, et al.. (2013). High potency improvements to weak aryl uracil HCV polymerase inhibitor leads. Bioorganic & Medicinal Chemistry Letters. 23(15). 4367–4369. 5 indexed citations
4.
Poordad, Fred, Eric Lawitz, Kris V. Kowdley, et al.. (2013). Exploratory Study of Oral Combination Antiviral Therapy for Hepatitis C. New England Journal of Medicine. 368(1). 45–53. 214 indexed citations
5.
Hutchinson, Douglas K., Charles A. Flentge, Rolf Wagner, et al.. (2011). Hepatitis C NS5B polymerase inhibitors: Functional equivalents for the benzothiadiazine moiety. Bioorganic & Medicinal Chemistry Letters. 21(6). 1876–1879. 7 indexed citations
6.
Randolph, John T., Charles A. Flentge, Peggy Huang, et al.. (2009). Synthesis and Biological Characterization of B-Ring Amino Analogues of Potent Benzothiadiazine Hepatitis C Virus Polymerase Inhibitors. Journal of Medicinal Chemistry. 52(10). 3174–3183. 34 indexed citations
7.
Mondal, Rubina, Gennadiy Koev, Edward Tam, et al.. (2009). Development of a cell-based assay for high-throughput screening of inhibitors against HCV genotypes 1a and 1b in a single well. Antiviral Research. 82(1). 82–88. 14 indexed citations
8.
Pratt, John K., Clarence J. Maring, Warren M. Kati, et al.. (2008). Des-A-ring benzothiadiazines: Inhibitors of HCV genotype 1 NS5B RNA-dependent RNA polymerase. Bioorganic & Medicinal Chemistry Letters. 18(8). 2735–2738. 16 indexed citations
9.
10.
Koev, Gennadiy & Warren M. Kati. (2008). The emerging field of HCV drug resistance. Expert Opinion on Investigational Drugs. 17(3). 303–319. 38 indexed citations
11.
Masse, Sherie, Xiaozhi Lu, Tatyana Dekhtyar, et al.. (2007). In Vitro Selection and Characterization of Human Immunodeficiency Virus Type 2 with Decreased Susceptibility to Lopinavir. Antimicrobial Agents and Chemotherapy. 51(9). 3075–3080. 25 indexed citations
12.
Larson, Daniel P., Rolf Wagner, Todd W. Rockway, et al.. (2007). Synthesis and SAR of novel 1,1-dialkyl-2(1H)-naphthalenones as potent HCV polymerase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(2). 568–570. 16 indexed citations
13.
Ng, Teresa I., Hongmei Mo, Edward Tam, et al.. (2007). Identification of host genes involved in hepatitis C virus replication by small interfering RNA technology. Hepatology. 45(6). 1413–1421. 105 indexed citations
14.
Middleton, Tim, Yupeng He, Edward Tam, et al.. (2007). A replicon-based shuttle vector system for assessing the phenotype of HCV NS5B polymerase genes isolated from patient populations. Journal of Virological Methods. 145(2). 137–145. 25 indexed citations
15.
Koev, Gennadiy, Tatyana Dekhtyar, Ping Yan, et al.. (2006). Antiviral interactions of an HCV polymerase inhibitor with an HCV protease inhibitor or interferon in vitro. Antiviral Research. 73(1). 78–83. 24 indexed citations
16.
Koev, Gennadiy, Roger F. Duncan, & Michael M. C. Lai. (2002). Hepatitis C Virus IRES-Dependent Translation Is Insensitive to an eIF2α-Independent Mechanism of Inhibition by Interferon in Hepatocyte Cell Lines. Virology. 297(2). 195–202. 34 indexed citations
17.
Koev, Gennadiy, et al.. (2002). The 3′-Terminal Structure Required for Replication of Barley Yellow Dwarf Virus RNA Contains an Embedded 3′ End. Virology. 292(1). 114–126. 54 indexed citations
18.
Miller, Woutrina A. & Gennadiy Koev. (2000). Synthesis of Subgenomic RNAs by Positive-Strand RNA Viruses. Virology. 273(1). 1–8. 164 indexed citations
19.
Miller, W. Allen & Gennadiy Koev. (1998). Getting a handle on RNA virus recombination. Trends in Microbiology. 6(11). 421–423. 6 indexed citations
20.
Miller, W. Allen, et al.. (1997). Are There Risks Associated with Transgenic Resistance to Luteoviruses?. Plant Disease. 81(7). 700–710. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eric Ferrari Breakdown of academic impact, for papers by Shihyun You Breakdown of academic impact, for papers by Lucyna Cova Breakdown of academic impact, for papers by B. Wolanski Breakdown of academic impact, for papers by Kenneth A. Stapleford Breakdown of academic impact, for papers by Takashi Shimoike Breakdown of academic impact, for papers by Burton Beames Breakdown of academic impact, for papers by Katherine J. Denniston Breakdown of academic impact, for papers by Kevin Whitby Breakdown of academic impact, for papers by Jacquelyn Wright-Minogue
Rankless by CCL
2026